Stock Analysis on Net

AbbVie Inc. (NYSE:ABBV)

$24.99

Return on Assets (ROA)
since 2012

Microsoft Excel

Paying user area

The data is hidden behind: . Unhide it.

This is a one-time payment. There is no automatic renewal.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Calculation

AbbVie Inc., ROA, long-term trends, calculation

Microsoft Excel

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31).

1 US$ in millions

The analysis of the annual financial data reveals several notable trends in profitability, asset growth, and efficiency over the observed period.

Net Earnings Attributable
Net earnings displayed substantial volatility across the years. Initial earnings started strong at 5,275 million US dollars in 2012 but experienced a marked decline to 1,774 million in 2014. A recovery phase followed, peaking at 11,542 million in 2021, the highest within the span, before sharply declining again to 4,278 million by 2024. This fluctuation suggests periods of variable profitability and possible impacts from operational or market factors.
Total Assets
There was a general upward trajectory in total assets from 27,008 million US dollars in 2012, reaching a peak of 150,565 million in 2020. Afterwards, assets decreased somewhat but remained significantly elevated compared to the early years, indicating considerable company growth and investment in asset acquisition. The asset base more than quintupled over the period, reflecting expansion or strategic capitalization efforts.
Return on Assets (ROA)
ROA illustrated a declining trend from an exceptionally high 19.53% in 2012 to lower single-digit levels in later years, with some fluctuations. After initial strong returns, ROA dropped to as low as 3.07% in 2020, slightly recovering to 8.53% in 2021 before declining again toward 3.17% in 2024. This decrease in ROA, despite asset growth, signals diminishing efficiency in generating profits from the asset base over time.

Overall, the data depicts a company with significant asset expansion but variable and ultimately decreasing profitability efficiency. The sharp fluctuations in net earnings combined with declining ROA indicate challenges in sustaining profit margins despite a larger asset foundation.


Comparison to Competitors

AbbVie Inc., ROA, long-term trends, comparison to competitors

Microsoft Excel

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31).


Comparison to Sector (Pharmaceuticals, Biotechnology & Life Sciences)

AbbVie Inc., ROA, long-term trends, comparison to sector (pharmaceuticals, biotechnology & life sciences)

Microsoft Excel

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31).


Comparison to Industry (Health Care)

AbbVie Inc., ROA, long-term trends, comparison to industry (health care)

Microsoft Excel

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31).